Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Outcomes-Based Drug Pricing Still In Early Stages, HHS Forum Speakers Say

Executive Summary

Despite a few examples of outcomes-based pricing contracts in the US, comments at the HHS Pharmaceutical Forum suggest there are still significant obstacles preventing those types of contracts from being a near-term solution to high drug costs.



Related Companies